Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

Mormone E, George J, Nieto N.

Chem Biol Interact. 2011 Sep 30;193(3):225-31. doi: 10.1016/j.cbi.2011.07.001. Epub 2011 Jul 22. Review.

2.

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.

Su TH, Kao JH, Liu CJ.

Int J Mol Sci. 2014 Jun 12;15(6):10578-604. doi: 10.3390/ijms150610578. Review.

3.

Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.

Mormone E, Lu Y, Ge X, Fiel MI, Nieto N.

Gastroenterology. 2012 Mar;142(3):612-621.e5. doi: 10.1053/j.gastro.2011.11.029. Epub 2011 Dec 1.

4.

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.

Zhang CY, Yuan WG, He P, Lei JH, Wang CX.

World J Gastroenterol. 2016 Dec 28;22(48):10512-10522. doi: 10.3748/wjg.v22.i48.10512. Review.

5.

Hepatic stellate cells and the reversal of fibrosis.

Kisseleva T, Brenner DA.

J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S84-7. Review.

PMID:
16958681
6.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
7.

MicroRNA in hepatic fibrosis and cirrhosis.

Xin X, Zhang Y, Liu X, Xin H, Cao Y, Geng M.

Front Biosci (Landmark Ed). 2014 Jun 1;19:1418-24. Review.

PMID:
24896361
8.

Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.

Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E.

Dig Liver Dis. 2005 May;37(5):349-56.

PMID:
15843085
9.

Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.

Guido M, Rugge M, Leandro G, Fiel IM, Thung SN.

Hepatology. 1997 Aug;26(2):310-4.

PMID:
9252139
10.

Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.

Omar R, Yang J, Liu H, Davies NM, Gong Y.

Rev Physiol Biochem Pharmacol. 2016;172:1-37. Review.

PMID:
27534415
11.

Matrix metalloproteinase gene delivery for liver fibrosis.

Iimuro Y, Brenner DA.

Pharm Res. 2008 Feb;25(2):249-58. Epub 2007 Jun 19. Review.

12.

Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, Nieto N.

Hepatology. 2012 Feb;55(2):594-608. doi: 10.1002/hep.24701.

13.

Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.

Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E.

Ital J Anat Embryol. 2004 Oct-Dec;109(4):225-38.

PMID:
15717457
14.

Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair.

Iredale J.

Pharmacol Res. 2008 Aug;58(2):129-36. doi: 10.1016/j.phrs.2008.06.011. Epub 2008 Jul 4. Review.

PMID:
18652898
15.

Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.

McCrudden R, Iredale JP.

Histol Histopathol. 2000 Oct;15(4):1159-68. doi: 10.14670/HH-15.1159. Review.

PMID:
11005241
16.

Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice.

Ghatak S, Biswas A, Dhali GK, Chowdhury A, Boyer JL, Santra A.

Toxicol Appl Pharmacol. 2011 Feb 15;251(1):59-69. doi: 10.1016/j.taap.2010.11.016. Epub 2010 Dec 4.

17.

Pathophysiology and a Rational Basis of Therapy.

Gracia-Sancho J, Maeso-Díaz R, Bosch J.

Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6.

PMID:
26159267
18.

Liver Injury and the Activation of the Hepatic Myofibroblasts.

Jiang JX, Török NJ.

Curr Pathobiol Rep. 2013 Sep 1;1(3):215-223.

19.
20.

Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, Jares P, Bosch J, Arroyo V, Caballería J, Ginès P.

Gastroenterology. 2007 Feb;132(2):687-97. Epub 2006 Dec 20.

PMID:
17258719

Supplemental Content

Support Center